CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230
- in 4 filings, $2K under 10b5-1 plans
Net −$2,230. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Shaff Eric D. CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −7,813 | 78,125 | ||
| 2024-08-15 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +2,656 | 80,834 | ||
| 2024-08-15 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 26,563 | ||
| 2024-08-15 | Ege David S. See Remarks | Option exercise 10b5-1 | +2,969 | 78,703 | ||
| 2024-08-15 | Ege David S. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,969 | 29,688 | ||
| 2024-08-05 | Young Teresa L. See Remarks | Sale 10b5-1 | −24,480 | $1.08 | $27K | 78,178 |
| 2024-08-03 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +85,000 | 102,658 | ||
| 2024-08-03 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −85,000 | 0 | ||
| 2024-07-01 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +64,564 | 64,564 | ||
| 2024-07-01 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +64,564 | 64,564 | ||
| 2024-07-01 | Berenson Stephen Director | Grant or award · Stock Option (Right to Buy) | +114,782 | 114,782 | ||
| 2024-05-15 | von Moltke Lisa See Remarks | Option exercise 10b5-1 | +2,968 | 19,956 | ||
| 2024-05-15 | von Moltke Lisa See Remarks | Sale 10b5-1 | −939 | $0.94 | $883 | 19,017 |
| 2024-05-15 | von Moltke Lisa See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,968 | 32,657 | ||
| 2024-05-15 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +7,812 | 143,133 | ||
| 2024-05-15 | Shaff Eric D. CEO and President | Sale 10b5-1 | −2,435 | $0.94 | $2K | 140,698 |
| 2024-05-15 | Shaff Eric D. CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −7,812 | 85,938 | ||
| 2024-05-15 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +2,656 | 18,361 | ||
| 2024-05-15 | Young Teresa L. See Remarks | Sale 10b5-1 | −703 | $0.94 | $661 | 17,658 |
| 2024-05-15 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 29,219 |
Page 12 of 13 · 254 trades